Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 206

    1.

    High-sensitive troponin T is associated with atrial fibrillation in a general population.

    Anegawa T, Kai H, Adachi H, Hirai Y, Enomoto M, Fukami A, Otsuka M, Kajimoto H, Yasuoka S, Iwamoto Y, Aoki Y, Fukuda K, Imaizumi T.

    Int J Cardiol. 2012 Apr 5;156(1):98-100. Epub 2012 Jan 21. No abstract available.

    PMID:
    22264874
    [PubMed - in process]
    2.

    Survival benefit of new anticoagulants compared with warfarin in patients with atrial fibrillation: a meta-analysis.

    Liu T, Korantzopoulos P, Li L, Li G.

    Int J Cardiol. 2012 Apr 5;156(1):96-7. Epub 2012 Jan 16. No abstract available.

    PMID:
    22257690
    [PubMed - in process]
    3.

    Prevalence and spectrum of GATA6 mutations associated with familial atrial fibrillation.

    Yang YQ, Wang XH, Tan HW, Jiang WF, Fang WY, Liu X.

    Int J Cardiol. 2012 Mar 22;155(3):494-6. Epub 2012 Jan 16. No abstract available.

    PMID:
    22257684
    [PubMed - in process]
    4.

    Updates on new oral anticoagulants and percutaneous devices for stroke prevention in patients with non-valvular atrial fibrillation.

    Kwong JS, Lam YY.

    Int J Cardiol. 2012 Mar 8;155(2):340-1. Epub 2012 Jan 10. No abstract available.

    PMID:
    22240766
    [PubMed - in process]
    5.

    Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation.

    Chiang CE, Zhang S, Tse HF, Teo WS, Omar R, Sriratanasathavorn C.

    Int J Cardiol. 2012 Jan 10. [Epub ahead of print]

    PMID:
    22240753
    [PubMed - as supplied by publisher]
    6.

    Prevalence of asymptomatic and electrically undetectable intracardiac inside-out abrasion in silicon-coated Riata® and Riata® ST implantable cardioverter-defibrillator leads.

    Schmutz M, Delacrétaz E, Schwick N, Roten L, Fuhrer J, Boesch C, Tanner H.

    Int J Cardiol. 2012 Jan 9. [Epub ahead of print]

    PMID:
    22236515
    [PubMed - as supplied by publisher]
    7.

    Electrocardiographic abnormalities and risk of complete atrioventricular block.

    Watanabe H, Makita N, Tanabe N, Watanabe T, Aizawa Y.

    Int J Cardiol. 2012 Mar 22;155(3):462-4. Epub 2012 Jan 5. No abstract available.

    PMID:
    22225759
    [PubMed - in process]
    8.

    Tackling myocardial metabolism: one year evaluation of free fatty acids, norephinephrine and NT-proBNP in ventricular fibrillation during STEMI.

    Behnes M, Kälsch T, Lang S, Süselbeck T, Borggrefe M, Elmas E.

    Int J Cardiol. 2012 Mar 8;155(2):291-3. Epub 2012 Jan 2. No abstract available.

    PMID:
    22217481
    [PubMed - in process]
    9.

    Marked lipomatous hypertrophy of the right ventricular wall: a distinct clinicopathological entity from arrhythmogenic right ventricular cardiomyopathy?

    Nakajima T, Kaneko Y, Fukuda N, Irie T, Iso T, Kurabayashi M.

    Int J Cardiol. 2012 Feb 9;154(3):379-80. Epub 2011 Dec 26. No abstract available.

    PMID:
    22204856
    [PubMed - in process]
    10.

    Early mineralocorticoid receptor blockade in primary percutaneous coronary intervention for ST-elevation myocardial infarction is associated with a reduction of life-threatening ventricular arrhythmia.

    Beygui F, Labbé JP, Cayla G, Ennezat PV, Motreff P, Roubille F, Silvain J, Barthélémy O, Delarche N, Van Belle E, Collet JP, Montalescot G.

    Int J Cardiol. 2011 Dec 24. [Epub ahead of print]

    PMID:
    22200184
    [PubMed - as supplied by publisher]
    11.

    Osteoprotegerin/RANK/RANKL axis and atrial remodeling in mitral valvular patients with atrial fibrillation.

    Cao H, Li Q, Li M, Od R, Wu Z, Zhou Q, Cao B, Chen B, Chen Y, Wang D.

    Int J Cardiol. 2011 Dec 15. [Epub ahead of print]

    PMID:
    22178057
    [PubMed - as supplied by publisher]
    12.

    Short-term onset of fatal pulmonary toxicity in a patient treated with intravenous amiodarone for post-operative atrial fibrillation.

    Boriani G, Ferruzzi L, Corti B, Ruffato A, Gavelli G, Mattioli S.

    Int J Cardiol. 2011 Nov 28. [Epub ahead of print] No abstract available.

    PMID:
    22130226
    [PubMed - as supplied by publisher]
    13.

    Vernakalant: Conversion of atrial fibrillation in patients with ischemic heart disease.

    Torp-Pedersen C, Camm AJ, Butterfield NN, Dickinson G, Beatch GN.

    Int J Cardiol. 2011 Nov 21. [Epub ahead of print]

    PMID:
    22108512
    [PubMed - as supplied by publisher]
    14.

    Comparison of the reliability and validity of four contemporary risk stratification schemes to predict thromboembolism in non-anticoagulated patients with atrial fibrillation.

    Abu-Assi E, Otero-Raviña F, Allut Vidal G, Coutado Méndez A, Vaamonde Mosquera L, Sánchez Loureiro M, Caneda Villar MC, Fernández Villaverde JM, Maestro Saavedra FJ, González-Juanatey JR; on behalf of Grupo Barbanza researchers.

    Int J Cardiol. 2011 Nov 19. [Epub ahead of print]

    PMID:
    22104995
    [PubMed - as supplied by publisher]
    15.

    Insufficient compliance with current implantable cardioverter defibrillator (ICD) therapy guidelines in post myocardial infarction patients is associated with increased mortality.

    Pertzov B, Novack V, Zahger D, Katz A, Amit G.

    Int J Cardiol. 2011 Nov 16. [Epub ahead of print]

    PMID:
    22100182
    [PubMed - as supplied by publisher]
    16.

    Overexpression of cAMP-response element modulator causes abnormal growth and development of the atrial myocardium resulting in a substrate for sustained atrial fibrillation in mice.

    Kirchhof P, Marijon E, Fabritz L, Li N, Wang W, Wang T, Schulte K, Hanstein J, Schulte JS, Vogel M, Mougenot N, Laakmann S, Fortmueller L, Eckstein J, Verheule S, Kaese S, Staab A, Grote-Wessels S, Schotten U, Moubarak G, Wehrens XH, Schmitz W, Hatem S, Müller FU.

    Int J Cardiol. 2011 Nov 15. [Epub ahead of print]

    PMID:
    22093963
    [PubMed - as supplied by publisher]
    17.

    Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: a speckle tracking study.

    Henein M, Zhao Y, Henein MY, Lindqvist P.

    Int J Cardiol. 2012 Mar 22;155(3):437-41. Epub 2011 Nov 15.

    PMID:
    22088228
    [PubMed - in process]
    18.

    The incidence and characteristics of supraventricular tachycardia in left atrial isomerism: A high incidence of atrial fibrillation in young patients.

    Miyazaki A, Sakaguchi H, Ohuchi H, Yamamoto T, Igarashi T, Negishi J, Toyota N, Kagisaki K, Yagihara T, Yamada O.

    Int J Cardiol. 2011 Nov 12. [Epub ahead of print]

    PMID:
    22082714
    [PubMed - as supplied by publisher]
    19.

    Navigating the fine line between benefit and risk in chronic atrial fibrillation: Rationale and design of the Standard versus Atrial Fibrillation spEcific managemenT studY (SAFETY).

    Carrington MJ, Ball J, Horowitz JD, Marwick TH, Mahadevan G, Wong C, Abhayaratna WP, Haluska B, Thompson DR, Scuffham PA, Stewart S.

    Int J Cardiol. 2011 Nov 11. [Epub ahead of print]

    PMID:
    22079383
    [PubMed - as supplied by publisher]
    20.

    Prevalence of atrial fibrillation in patients with history of paroxysmal supraventricular tachycardia.

    Khachab H, Brembilla-Perrot B.

    Int J Cardiol. 2011 Nov 10. [Epub ahead of print]

    PMID:
    22078397
    [PubMed - as supplied by publisher]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk